ＮＬＲＰ３インフラマソームの阻害剤

Title:

ＮＬＲＰ３インフラマソームの阻害剤

Document Type and Number:

Japanese Patent JP2024511204

Kind Code:

A

Abstract:

本開示は、ＮＬＲＰ３インフラマソームの阻害剤として作用する化合物、その化合物を含む薬学的組成物、ならびに聴力喪失及び加齢に関連する他の疾患を含む、炎症及び加齢炎症に関連する障害を処置する方法に関する。

More Like This:

JPH0662580	INDUSTRIAL APPLICABILITY: N- (aryloxyalkyl) heteroarylpiperidin and N- (aryloxyalkyl) heteroarylpiperazine
JP2020111510	INDAZOLE DERIVATIVE AND MEDICAMENT CONTAINING THE SAME
WO/2011/123947	SYNTHESIS OF CHIRAL 2-(1H-INDAZOL-6-YL)-SPIRO[CYCLOPROPANE-1,3'- INDOLIN]-2'-ONES

Inventors:

george hartman
Shu He
Jia Do
Lifan Jiang
paul humphries
Kevin Edward Leif Wilhelmsen

Application Number:

JP2023559145A

Publication Date:

March 12, 2024

Filing Date:

March 23, 2022

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Bioage Labs, Inc.
Hitgen Incorporated

International Classes:

C07D231/56; A61K31/416; A61K31/4164; A61K31/4184; A61K31/427; A61K31/437; A61K31/4439; A61K31/501; A61K31/538; A61P27/16; A61P29/00; A61P43/00; C07D401/12; C07D403/12; C07D405/12; C07D409/12; C07D409/14; C07D413/12; C07D417/12; C07D471/04

Attorney, Agent or Firm:

Yasuhiko Murayama
Shinya Mihiro
Tatsuhiko Abe

Previous Patent: electric machine

Next Patent: Supply of air and exhaust gas mixture to the compressor wheel of the compressor